Skip to content

West Pharmaceutical Services Inc

West Pharmaceutical Services

WST · NYSE

Healthcare

Catalog as of September 15, 2026. Not a live market feed.

Fiscal Year
2025
Revenue
$3.1B
Assets
$4.3B
SEC filing
DEF 14A
Filed
March 12, 2026

Executive Compensation

Compensation reported for West Pharmaceutical Services’ named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.

Eric M. Green

President and CEO, Chair of Board

$7.2M

Reported total · FY2025 · SCT Total as filed

Source: DEF 14A Summary Compensation Table, filed March 12, 2026.

Salary
$1.2M
Stock Awards
$3.3M
Option Awards
$1.1M
Incentives
$1.5M
Other
$106K

Historical Compensation

Eric M. Green total compensation, fiscal years 2023–2025.

Year-by-year total compensation
Fiscal YearSalaryTotal Compensation
2025$1,177,290$7,190,876
2024$1,170,696$8,394,201
2023$1,136,654$9,418,624

Named Executive Officers

Source information

Company
West Pharmaceutical Services Inc
Ticker
WST · NYSE
Filing type
DEF 14A
Fiscal year
2025
Filing date
March 12, 2026
SEC accession number
0001104659-26-026778

Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing

Related Companies